Prevalence and risk factors for asymptomatic Clostridium difficile carriage
- PMID: 24755858
- PMCID: PMC4133563
- DOI: 10.1093/cid/ciu258
Prevalence and risk factors for asymptomatic Clostridium difficile carriage
Abstract
Background: Clostridium difficile infection (CDI) incidence has increased dramatically over the last decade. Recent studies suggest that asymptomatic carriers may be an important reservoir of C. difficile in healthcare settings. We sought to identify the prevalence and risk factors for asymptomatic C. difficile carriage on admission to the hospital.
Methods: Patients admitted to Barnes-Jewish Hospital without diarrhea were enrolled from June 2010 through October 2011. Demographic information and healthcare and medication exposures 90 days prior to admission were collected. Stool specimens or rectal swabs were collected within 48 hours of admission and stored at -30°C until cultured. Clostridium difficile isolates were typed and compared with isolates from patients with CDI.
Results: A stool/swab specimen was obtained for 259 enrolled subjects on admission. Two hundred four (79%) were not colonized, 40 (15%) had toxigenic C. difficile (TCD), and 15 (6%) had nontoxigenic C. difficile. There were no differences between TCD-colonized and -uncolonized subjects for age (mean, 56 vs 58 years; P = .46), comorbidities, admission from another healthcare facility (33% vs 24%; P = .23), or recent hospitalization (50% vs 50%; P = .43). There were no differences in antimicrobial exposures in the 90 days prior to admission (55% vs 56%; P = .91). Asymptomatic carriers were colonized with strains similar to strains from patients with CDI, but the relative proportions were different.
Conclusions: There was a high prevalence of TCD colonization on admission. In contrast to past studies, TCD colonization was not associated with recent antimicrobial or healthcare exposures. Additional investigation is needed to determine the role of asymptomatic TCD carriers on hospital-onset CDI incidence.
Keywords: Clostridium difficile colonization; asymptomatic carrier; prevalence; risk factors.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Colonization of Toxigenic Clostridium difficile Among Intensive Care Unit Patients: A Multi-Centre Cross-Sectional Study.Front Cell Infect Microbiol. 2020 Jan 30;10:12. doi: 10.3389/fcimb.2020.00012. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32083021 Free PMC article.
-
Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease.Clin Microbiol Infect. 2019 Sep;25(9):1127-1132. doi: 10.1016/j.cmi.2019.02.002. Epub 2019 Feb 14. Clin Microbiol Infect. 2019. PMID: 30771530
-
Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains.PLoS One. 2017 Aug 16;12(8):e0182307. doi: 10.1371/journal.pone.0182307. eCollection 2017. PLoS One. 2017. PMID: 28813461 Free PMC article.
-
Clinical impact of Clostridium difficile colonization.J Microbiol Immunol Infect. 2015 Jun;48(3):241-8. doi: 10.1016/j.jmii.2014.04.011. Epub 2014 Jun 2. J Microbiol Immunol Infect. 2015. PMID: 24890755 Review.
-
Colonization versus carriage of Clostridium difficile.Infect Dis Clin North Am. 2015 Mar;29(1):13-28. doi: 10.1016/j.idc.2014.11.001. Epub 2015 Jan 13. Infect Dis Clin North Am. 2015. PMID: 25595843 Review.
Cited by
-
Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.Ann Clin Microbiol Antimicrob. 2024 Apr 25;23(1):35. doi: 10.1186/s12941-024-00696-1. Ann Clin Microbiol Antimicrob. 2024. PMID: 38664689 Free PMC article.
-
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29. Clin Microbiol Rev. 2024. PMID: 38421181 Review.
-
Prevalence of Non-Toxigenic Clostridioides difficile in Diarrhoea Patients and Their Clinical Characteristics.Antibiotics (Basel). 2023 Aug 24;12(9):1360. doi: 10.3390/antibiotics12091360. Antibiotics (Basel). 2023. PMID: 37760657 Free PMC article.
-
Environmental approaches to controlling Clostridioides difficile infection in healthcare settings.Antimicrob Resist Infect Control. 2023 Sep 7;12(1):94. doi: 10.1186/s13756-023-01295-z. Antimicrob Resist Infect Control. 2023. PMID: 37679758 Free PMC article. Review.
-
Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection.Front Cell Infect Microbiol. 2023 Jul 27;13:1190910. doi: 10.3389/fcimb.2023.1190910. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37577378 Free PMC article.
References
-
- Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377:63–73. - PubMed
-
- Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–9. - PubMed
-
- McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–41. - PubMed
-
- Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol. 2011;32:387–90. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
